Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Other Working Capital Changes of $2.3 million for Q1 2026, up 394.74% year-over-year from $464685.2 in Q1 2025, and up 103.78% quarter-over-quarter from -$60.8 million in Q3 2025.
Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Tango Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 394.74% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at -$59.3 million (down 7406.96% YoY), while the FY2025 annual figure was -$62.4 million, down 16760.54% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $2.3 million, up from -$60.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $8.8 million in Q3 2022, with the low at -$60.8 million in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$376000.0 (2023), against an average of -$4.7 million.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes soared 1091.13% in 2022, then slumped 4174.4% in 2025.
- Tango Therapeutics' Other Working Capital Changes stood at -$18.2 million in 2022, then soared by 122.44% to $4.1 million in 2023, then tumbled by 84.4% to $636000.0 in 2024, then plunged by 9658.18% to -$60.8 million in 2025, then jumped by 103.78% to $2.3 million in 2026.
- Business Quant data shows TNGX's Other Working Capital Changes at $2.3 million in Q1 2026, -$60.8 million in Q3 2025, and -$814000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.19 Mn |
| Jun 30, 2026 | 5.19 Mn |
| Jun 30, 2026 | 5.19 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Sep 30, 2025 | -60.79 Mn |
| Sep 30, 2025 | -60.79 Mn |
| Sep 30, 2025 | -60.79 Mn |
| Jun 30, 2025 | -814,000.00 |
| Jun 30, 2025 | -814,000.00 |
| Jun 30, 2025 | -814,000.00 |
| Mar 31, 2025 | -780,000.00 |
| Mar 31, 2025 | -780,000.00 |
| Mar 31, 2025 | -780,000.00 |
| Dec 31, 2024 | 636,000.00 |
| Dec 31, 2024 | 636,000.00 |
| Dec 31, 2024 | 636,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |